Cellosaurus logo
expasy logo

Cellosaurus Meso56 (CVCL_H681)

[Text version]
Cell line name Meso56
Synonyms MESO56; Meso 56
Accession CVCL_H681
Resource Identification Initiative To cite this cell line use: Meso56 (RRID:CVCL_H681)
Comments Omics: SNP array analysis.
Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
Sequence variations
  • Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=21642991).
Disease Pleural epithelioid mesothelioma (NCIt: C45662)
Pleural mesothelioma (ORDO: Orphanet_50251)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Category Cancer cell line
Publications

PubMed=21540305; DOI=10.1183/09031936.00160210
Roulois D., Vignard V., Gueugnon F., Labarriere N., Gregoire M., Fonteneau J.-F.
Recognition of pleural mesothelioma by mucin-1(950-958)/human leukocyte antigen A*0201-specific CD8+ T-cells.
Eur. Respir. J. 38:1117-1126(2011)

PubMed=21642991; DOI=10.1038/ng.855
Bott M.J., Brevet M., Taylor B.S., Shimizu S., Ito T., Wang L., Creaney J., Lake R.A., Zakowski M.F., Reva B., Sander C., Delsite R., Powell S.N., Zhou Q., Shen R.-L., Olshen A.B., Rusch V.W., Ladanyi M.
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.
Nat. Genet. 43:668-672(2011)

PubMed=21774103; DOI=10.1097/JTO.0b013e318215a07d
Brevet M., Shimizu S., Bott M.J., Shukla N., Zhou Q., Olshen A.B., Rusch V.W., Ladanyi M.
Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy.
J. Thorac. Oncol. 6:864-874(2011)

Cross-references
Cell line databases/resources cancercelllines; CVCL_H681
Biological sample resources BioSamples; SAMEA100840
Encyclopedic resources Wikidata; Q54905312
Gene expression databases GEO; GSM726277
Polymorphism and mutation databases Cosmic; 1522782
Cosmic; 1541206
Progenetix; CVCL_H681
Entry history
Entry creation11-Feb-2013
Last entry update05-Oct-2023
Version number13